5 “Strong Sell” Stocks on the Robinhood 100 to Avoid

Carefully analyze the Robinhood 100, and you are sure to find several stocks that are nothing but traps for inexperienced investors. Though the Robinhood 100 certainly has some bright spots, the plain truth of the matter is experienced investors look at the list with skepticism…

It is known far and wide that retail investors are generally bullish and willing to pour their money into unproven stocks and overvalued stocks. This is precisely why the Robinhood 100 is dotted with companies savvy investors avoid.

Let’s take a look at five “Strong Sell” Robinhood 100 stocks to bypass as we approach the new year: Carnival Corporation (CCL), Inovio Pharmaceuticals (INO), Sorrento Therapeutics (SRNE), iBio (IBIO), and AMC Entertainment (AMC).

Carnival Corporation (CCL)

The cruise business might be the worst industry to invest in at this moment in time. The virus is coming back, possibly stronger than before, putting the entire cruise industry in jeopardy.

CCL might be one of the more attractive cruise stocks, yet it is clearly unworthy of investor dollars considering the context. Don’t buy into the hype as Robinhood traders have. Perform an honest assessment of this stock, and you will find it is too risky for your hard-earned money.

The POWR Ratings show CCL has “F” grades in the Industry Rank, Trade Grade, and Buy & Hold Grade components. Of the eight analysts who have studied CCL, six recommend holding, one advises selling, and only one recommends buying. Travel restrictions across the globe brought about by a second wave of the virus should send CCL even lower.

Inovio Pharmaceuticals (INO)

INO develops human uses for electroporation that transmits controlled electrical pulses to boost the cellular uptake of biopharmaceuticals. INO has terrible POWR Ratings: “F” grades in the Buy & Hold and Trade Grade components, along with a “D” Peer Grade. Furthermore, INO barely cracks the top 200 of Biotech stocks in our database.

Of the eight analysts who have studied INO…

Continue reading at STOCKNEWS.com



Leave a Reply

Your email address will not be published.